Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Chapman

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Pigment Cell Research|September 14, 2007
Detection of melanoma cells in sentinel lymph nodes by PCR is not yet ready for prime timePaul B Chapman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating LymphocytesPaul B Chapman
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibodyPaul B Chapman
Hematology/Oncology Clinics of North America|June 10, 2006
Immunotherapy of melanomaPetra Rietschel, Paul B Chapman
The New England Journal of Medicine|February 20, 2004
Defining adequate surgery for primary melanomaSusan E Krown, Paul B Chapman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
The Role of Neoadjuvant Trials in Drug Development for Solid TumorsSamuel A Funt, Paul B Chapman
Hematology/Oncology Clinics of North America|May 26, 2009
The history and future of chemotherapy for melanomaArvin S Yang, Paul B Chapman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
How can we tell when cancer vaccines vaccinate?Jedd D Wolchok, Paul B Chapman
The Lancet. Oncology|March 13, 2017
A step forward for patients with NRAS-mutant melanomaMichael A Postow, Paul B Chapman
Cancer Journal (Sudbury, Mass.)|March 25, 2024
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic DiseaseJames W Smithy, Paul B Chapman
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Pigment Cell Research|September 14, 2007
Detection of melanoma cells in sentinel lymph nodes by PCR is not yet ready for prime timePaul B Chapman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating LymphocytesPaul B Chapman
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibodyPaul B Chapman
Hematology/Oncology Clinics of North America|June 10, 2006
Immunotherapy of melanomaPetra Rietschel, Paul B Chapman
The New England Journal of Medicine|February 20, 2004
Defining adequate surgery for primary melanomaSusan E Krown, Paul B Chapman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
The Role of Neoadjuvant Trials in Drug Development for Solid TumorsSamuel A Funt, Paul B Chapman
Hematology/Oncology Clinics of North America|May 26, 2009
The history and future of chemotherapy for melanomaArvin S Yang, Paul B Chapman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
How can we tell when cancer vaccines vaccinate?Jedd D Wolchok, Paul B Chapman
The Lancet. Oncology|March 13, 2017
A step forward for patients with NRAS-mutant melanomaMichael A Postow, Paul B Chapman
Cancer Journal (Sudbury, Mass.)|March 25, 2024
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic DiseaseJames W Smithy, Paul B Chapman
Pageof 15